• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Agtira: Big launch and a capital-light expansion in the cards - Emergers

AGTIRA BThird party research2024-08-19 11:11

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
In terms of financials, Q2 was largely a repeat of Q1, with one-off replanting and remediation costs from the Q1 disease affecting the results. The production start in Haninge in Q4’24 will increase annual production rate to SEK 60m. With upcoming establishments in Kramfors (2,000 + 6,000 m²), Boden, and Coop Nord (where we are more uncertain about prospects), Agtira could raise ARR to SEK 120m, though this may take longer than expected. Our updated sales forecast is SEK 42m for 2024e and SEK 70m for 2025e. With SEK 20m in fresh financing and a more capital-light expansion strategy (via NP3 and Newsec partnerships), we now find support for a fair value of SEK 9-11 (previously 10-13) per share, factoring in a SEK 30m raise in 2025.